Research
Significant milestone for brachyury drug discovery: Announcing the first winner of the TBXT Challenge
9/14/2026
A longstanding hurdle to developing drugs targeting chordoma’s key vulnerability and defining feature, brachyury, has been overcome, potentially paving the way for treatments aimed at this historically “undruggable” target.
View Post